Friday, 29 Aug 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Jockey Club unveils first Hong Kong, China member of global pop group Now United, supporting young local talent to shine on world stage
    Jockey Club unveils first Hong Kong, China member of global pop group Now United, supporting young local talent to shine on world stage
    29/08/2025
    CGTN: History Illuminates the Future
    CGTN: History Illuminates the Future
    29/08/2025
    CATL Unveils TENER Stack at Smarter E South America 2025, Expands Presence in South America
    CATL Unveils TENER Stack at Smarter E South America 2025, Expands Presence in South America
    28/08/2025
    U. S. Air Force Global Strike Command Reinstates the M18 Pistol
    U. S. Air Force Global Strike Command Reinstates the M18 Pistol
    28/08/2025
    IBM and AMD Join Forces to Build the Future of Computing
    IBM and AMD Join Forces to Build the Future of Computing
    27/08/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • june
  • global
  • Business
  • july
  • today
  • announced
  • aug
  • company
  • Tech
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

PRNW Agency
Last updated: 09/08/2025 2:31 AM
PRNW Agency
Share
6 Min Read
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
SHARE
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS’s multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types of breast cancer. It will also support the potential development of a bespoke AI-powered predictive model aimed at optimizing outcomes for individuals undergoing treatment for breast cancer.

- Advertisement -

Derived from cutting-edge computing protocols and trained on one of the most diverse multimodal datasets in healthcare, SOPHiA GENETICS’s AI Factories offer powerful predictive insights for assessing patient prognosis and treatment response. AstraZeneca will utilize SOPHiA GENETICS’s AI Factories to analyze multimodal healthcare data — including genomics, imaging, and clinical data — and generate AI-powered insights to help optimize breast cancer outcomes. The companies will also collaborate on real-world evidence generation in Europe and North America to uncover key drivers of treatment efficacy, address critical knowledge gaps, and enhance clinical decision-making through deeper insights.

- Advertisement -

“We are proud to deepen our partnership with AstraZeneca through this significant new initiative, which highlights the growing demand for secure, compliant, and scalable real-world AI applications,” said Ross Muken, President of SOPHiA GENETICS. “Our platform is purpose-built to manage complex healthcare data environments, and this collaboration reinforces our shared commitment to driving better patient outcomes through trusted, federated analytics powered by data and AI.”

“At AstraZeneca, a core component of our AI strategy has been rooted in the deployment of frontier AI solutions across oncology clinical development,” said Jorge Reis-Filho, Chief AI and Data Scientist, AstraZeneca. “Fine tuning and augmenting our models with multimodal data – including our own data and the data that will be generated as part of this collaboration – is helping us to generate a more holistic understanding of disease biology and biomarkers to tailor the most effective treatment to patients living with cancer.”

- Advertisement -

This collaboration reinforces SOPHiA GENETICS’ position as a trusted technology partner and underlines its commitment to advancing global health through federated data analytics and artificial intelligence.

- Advertisement -

For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn. 

About SOPHiA GENETICS  

- Advertisement -

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn. 

- Advertisement -

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence. 

SOPHiA GENETICS Forward-Looking Statements:  

- Advertisement -

This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. 

- Advertisement -

Logo – https://mma.prnewswire.com/media/1673202/SOPHiA_GENETICS_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/sophia-genetics-expands-collaboration-with-astrazeneca-using-ai-to-improve-breast-cancer-patient-outcomes-302521041.html

- Advertisement -
Glow & Lovely Launches ‘Apni Roshni Baahar La’, a Nationwide Movement to Empower Women to Lead, Influence and Shine
Infinite Uptime Unlocks Production Reliability for Heavy Industries with PlantOS at Global Steel Dynamics Forum
Enovis to Participate in Upcoming Investor Conferences
PharmAla Issues Q3 Financial Statements
Axtria Recognized in Two Gartner Hype Cycle Reports for 2025 for Advancing Data Science and Analytics in Life Sciences
TAGGED: withaipoweredalsoastrazenecaaugbostonbreastcancerclinicalcollaborationdataefficacyevidenceexpandsfactoriesgenerategeneticsgeneticsshealthcareimproveinsightsmultimodalnasdaqnewsoutcomespartnershippatientpredictiverealworldrollesophiaswitzerlandtreatmentusingwill
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Industry Expert Warns Gym Operators Against Costly Access Control Vendor Lock-In
Sports

Industry Expert Warns Gym Operators Against Costly Access Control Vendor Lock-In

09/07/2025
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
Health

ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope

16/06/2025
15below Acquires Airport AI to Build the First Connected Communications Solution for Air Travel
Travel

15below Acquires Airport AI to Build the First Connected Communications Solution for Air Travel

09/07/2025
YXT.com’s AI Learning Platform Deployed by Siemens for Digital Workforce Transformation
Tech

YXT.com’s AI Learning Platform Deployed by Siemens for Digital Workforce Transformation

09/06/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?